AU2003298261A1 - Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway - Google Patents

Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway

Info

Publication number
AU2003298261A1
AU2003298261A1 AU2003298261A AU2003298261A AU2003298261A1 AU 2003298261 A1 AU2003298261 A1 AU 2003298261A1 AU 2003298261 A AU2003298261 A AU 2003298261A AU 2003298261 A AU2003298261 A AU 2003298261A AU 2003298261 A1 AU2003298261 A1 AU 2003298261A1
Authority
AU
Australia
Prior art keywords
alpha
tnf
necrosis
tumor
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298261A
Other versions
AU2003298261A8 (en
Inventor
Angela Bauch
Andreas Bauer
Tewis Bouwmeester
Bettina Huhse
Ulrich Kruse
Bernhard Kuster
Heinz Ruffner
Giulio Superti-Furga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellzome GmbH
Original Assignee
Cellzome GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20020021809 external-priority patent/EP1403282A1/en
Application filed by Cellzome GmbH filed Critical Cellzome GmbH
Publication of AU2003298261A1 publication Critical patent/AU2003298261A1/en
Publication of AU2003298261A8 publication Critical patent/AU2003298261A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003298261A 2002-09-26 2003-09-24 Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway Abandoned AU2003298261A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20020021809 EP1403282A1 (en) 2002-09-26 2002-09-26 Protein complexes of the Tumor necrosis factor-alpha (TNF-alpha) signalling pathway
EP02021809.5 2002-09-26
EP03100274 2003-02-10
EP03100274.4 2003-02-10
PCT/EP2003/050655 WO2004035783A2 (en) 2002-09-26 2003-09-24 Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway

Publications (2)

Publication Number Publication Date
AU2003298261A1 true AU2003298261A1 (en) 2004-05-04
AU2003298261A8 AU2003298261A8 (en) 2004-05-04

Family

ID=32109134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298261A Abandoned AU2003298261A1 (en) 2002-09-26 2003-09-24 Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway

Country Status (2)

Country Link
AU (1) AU2003298261A1 (en)
WO (1) WO2004035783A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054284A2 (en) * 2003-11-28 2005-06-16 Medical Research Council Regulation involving abin-2
AU2008329518A1 (en) 2007-11-27 2009-06-04 Viventia Biotechnologies Inc. Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereof
EP4060344A1 (en) 2015-06-08 2022-09-21 Arquer Diagnostics Limited Methods and kits
CN107771285A (en) 2015-06-08 2018-03-06 阿奎尔诊断有限公司 Method
CN114878833A (en) * 2021-07-01 2022-08-09 浙江大学 Kit for detecting anti-peroxiredoxin-1-IgG antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437113B1 (en) * 1998-03-05 2002-08-20 Tularik Inc. Suppressors of death domains

Also Published As

Publication number Publication date
WO2004035783A9 (en) 2004-09-30
AU2003298261A8 (en) 2004-05-04
WO2004035783A2 (en) 2004-04-29
WO2004035783A3 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AU2003256813A1 (en) Medical tele-robotic system
AU2003261987A1 (en) Spotlight
AU2003243436A1 (en) Reconstituted polypeptides
AU2003282484A1 (en) Nipple
AU2003255831A1 (en) Delayed-gelation solution
AU2003263973A1 (en) Open medical system
AUPS032202A0 (en) Teether
AU2003289742A1 (en) Stable therapeutic proteins
AUPR279101A0 (en) Protein kinase signalling
AU2003290563A1 (en) Leptin-related peptides
AU2003272454A1 (en) Protein purification
AU2003262380A1 (en) Signaling assembly
AU2003225394A1 (en) Necktie wearing-device
AU2003298261A1 (en) Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway
AU2003205623A1 (en) Prion protein carrier-conjugates
AU2003202694A1 (en) Torero protein
AU2003302330A1 (en) Antimicrobial peptides
AU2003254001A1 (en) Novel htnfsf13b protein variants
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003300785A1 (en) Carbohydrate-associated proteins
AU2003280601A1 (en) Drug containing angiotensin convertase
AU2003254865A1 (en) Akt2-BINDING PROTEIN
AU2003272040A1 (en) Surface-mounting system
AU2003236908A1 (en) Proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase